Several co-culture systems incorporating fibroblasts and endothelial cells have been used to characterize cell-cell and cell-matrix interactions critical for angiogenesis. However, these models do not provide a means for translation to clinical application. Here, we develop an approach that may facilitate in vivo neovascularization utilizing the advantages of both proangiogenic co-culture and collagen microthreads. This system could also serve as an in vitro tool to study angiogenic mechanisms. Self-assembled collagen microthreads populated with human dermal fibroblasts (HDFs) were extruded using a novel method. Human umbilical vein endothelial cells (HUVECs) were then seeded on the surface of the HDF-populated collagen microthreads. Fluorescence microscopy confirmed the presence of both cell types after 24 hours of co-culture and phalloidin staining was used to visualize cell morphology. These results demonstrate that co-cultures can be established using a collagen microthread platform, which may ultimately allow concurrent delivery of two therapeutic cell types.
II. Introduction
Therapeutic neovascularization has emerged as a potentially effective solution for the clinical concerns of tissue necrosis, insufficient perfusion, and diminished functionality commonly associated with ischemia-related diseases [1] . The enhancement of angiogenesis toward more efficient and complete wound healing has been studied extensively both in vivo and in vitro, yet there remains a need for a delivery platform that will facilitate guided ingrowth of native therapeutic cells from the wound margin deep into the wound. Physiological angiogenesis occurs through a highlyregulated cascade of endothelial cell activation, migration, proliferation, and tubule formation whereby new vasculature sprouts from pre-existing vessels [2] . Despite the critical role of endothelial cells in neovascular formation, therapeutic delivery of endothelial cells alone is not sufficient because the cells are not presented with the full complement of environmental cues that are required for proper angiogenesis [3] . Temporal, spatial, and dose-controlled exposure to a number of angiogenic and angiostatic growth factors is required for angiogenesis to occur [4, 5] . In vivo, periendothelial cells including fibroblasts serve as an abundant source of such angiogenic factors, activating ECs, promoting EC cell-cell contact, and directing angiogenesis [6] . Further, these cells produce extracellular matrix proteins that provide structural and biochemical support for the neovasculature [7] . Several groups have developed co-culture systems consisting of these two cell types to assess the role of each in angiogenesis. Using a co-culture model system consisting of endothelial cells and fibroblasts in a collagen gel, such studies have demonstrated induced angiogenesis in vitro as evidenced by EC activation, migration, and the formation of tube-like structures [2] . These models used collagen hydrogels and sponges to provide essential threedimensional support and signaling templates for cellular interactions. However, the effectiveness of such scaffolds may be restricted by generally poor mechanical properties, limited mass transport, and an inability to translate directly to clinical application [8] . Previously, small diameter fiber scaffolds derived from natural polymers have demonstrated improved mechanical strength as well as the ability to facilitate contact guidance, alignment, and orientation of cells [9] . In this study, we developed a novel collagen microthreadbased co-culture system consisting of encapsulated human dermal fibroblasts and surface-seeded human umbilical vein endothelial cells. This model will serve as a platform for the further characterization of the cell-cell and cell-matrix interactions that are critical for therapeutic angiogenesis and may ultimately serve as a cell delivery vehicle that promotes guided vessel formation in vivo.
III. Materials and Methods

Cell culture and DiI-Ac-LDL labeling of HUVECs
Human dermal fibroblasts (HDFs, primary isolates from neonatal foreskin tissue) at passage 12 and human umbilical vein endothelial cells (HUVECs, primary isolates, Lonza, Mapleton, IL) at passage 8 were used in this study. HDFs were cultured in DMEM (Mediatech, Herndon, VA) supplemented with 10% FBS (PAA, Ontario, Canada) and 1% penicillin/streptomycin (Mediatech, Herndon, VA). At 90% confluence, the HDFs were trypsinized and resuspended at a concentration of 180,000 cells/mL.
HUVECs were cultured with EGM media (Lonza, Mapleton, IL) at 37°C. At 80% confluence, the HUVECs were trypsinized and re-suspended at a concentration of 66,000 cells/mL. To differentiate between the two cell types, the HUVECs were pre-loaded with DiI-Ac-LDL [10] prior to surface seeding.
HDF-populated collagen thread extrusion
Fibroblast-populated self-assembled collagen threads were produced using a novel extrusion method. Acid-soluble type I collagen was mixed with 5X DMEM and human dermal fibroblast cell suspension at a 4:1:3 ratio. The three solutions were mixed thoroughly and extruded through a polyethylene tube with inner diameter of 0.86 mm into fiber formation buffer (FFB; pH 7.42, 135 mM NaCl, 30 mM TrizmaBase, and 5 mM NaPO4 dibasic; Sigma, St. Louis, MO). The threads were incubated for 30 minutes in FFB at 37°C before transfer to DMEM culture media. These HDF-populated threads were cultured for 24 hours before seeding HUVECs on the surface. Acellular control threads were also extruded using the same method, substituting DMEM for the cell suspension.
HUVEC surface seeding
After 24 hours in culture in DMEM culture media, acellular control threads and HDF-populated threads were transferred to custom-built PDMS seeding devices for surface seeding. The devices provide a constrained volume and geometry that facilitates cell contact and adhesion to the curved surface of the collagen microthreads. One hundred microliters of HUVECs suspension was carefully pipetted into each channel and the threads were incubated for 4 hours. Microthreads were then washed in PBS and transferred to EGM media for culture at 37°C. Cultures were observed 24 hours after HUVEC seeding.
Fluorescent labeling of cell cultures
Cell-seeded collagen microthreads were removed from culture every 24 hours for observation. Each sample was placed on a glass slide, fixed with 4% paraformaldehyde, and stained with phalloidin to visualize cell morphology and Hoechst to visualize cell nuclei. This staining is in addition to the DiI-Ac-LDL pre-loaded into HUVECs as described in Materials & Methods.
IV. Results and Conclusions
Fluorescent imaging of the cell-seeded constructs confirmed encapsulation of HDFs and surface attachment of HUVECs at all time points (0-48 hours). HDF presence was determined by the co-localization of the F-actin (green, phalloidin stain) with a nucleus (blue, Hoechst stain). HUVECs were distinguished by the added presence of DiI (orange). Panels A and B of Figure 1 show an HDF/HUVEC collagen thread after 24 of co-culture. Visualization throughout the thickness and along the length of the thread confirmed uniform seeding of both encapsulated HDFs and surface-seeded HUVECs. Panels C and D show an HDF-seeded thread construct 4 hours and 24 hours after extrusion, respectively. The HDFs at 4 hours after extrusion exhibited very limited spreading.
HDFs showed increasingly spread morphology 24 hours after extrusion. Panels E and F show an acellular collagen thread 24 hours after HUVEC seeding. HDF and HUVEC monoculture control experiments were performed to validate HDF encapsulation and HUVEC surface seeding methods. The attachment and morphology of both cell types after 24 hours of co-culture demonstrate that the HDF/HUVEC co-culture system was effectively translated to a collagen microthread scaffold. By carrying these co-cultures to longer time points, it will be possible to observe and characterize cell-cell and cell-matrix that are critical for angiogenesis. This novel microthread-based cellular co-culture system may therefore serve as both a platform for the study of angiogenic mechanisms and a vehicle for concurrent delivery of two therapeutic cell types. Thus, future work will seek to characterize the advantages of this system as an in vitro bench-top model as well as an implantable construct to facilitate angiogenesis in vivo.
